Abstract: An implantable medical device comprising a coronary perfusion measurement unit is adapted to measure and determine parameters related to coronary perfusion of heart tissue. The parameters include time periods and perfusion magnitudes. The coronary perfusion measurement unit is configured to determine a time period T related to a perfusion event of a coronary vessel and including includes a reperfusion time period, where a perfusion event is defined as a decrease of coronary perfusion followed by reperfusion, and to generate a time period signal in dependence thereto. The implantable medical device further comprises a coronary flow calculation unit that is adapted to receive the time period signal and that is adapted to process the time period and to generate an ischemia risk indicating index I in dependence of the time period.

Abstract: A medical implantable lead is adapted to be implanted into a human or animal body for monitoring and/or controlling of an organ inside the body, and has in a distal end, a combined fixation means and electrode member in form of a helix, which is rotatable in relation to the lead and extendable out from the distal end by rotation of a tubular torque transferring member. The helix is electrically connected to a connector in the proximal end by at least one electrically conducting wire, which is formed as an electrically conducting coil, which is separate from the tubular torque transferring member and that includes one or more individual wires each having an electrically conducting wire core and a surrounding electrically insulating layer. The tubular torque transferring member has no electrically conducting function to or from the helix.

Abstract: An implantable medical device, IMD, (100) conducts CRT settings searches at multiple CRT settings search periods during an optimization time period by testing different candidate CRT settings and selecting the optimal CRT setting based on output signals of a hemodynamic sensor (240). The respective optimal CRT settings determined during the optimization time period are employed in order to predict at least one future optimal CRT setting that can be used by the IMD (100) following the end of the optimization time period. The IMD (100) then generates and applies pacing pulses to a subject's (5) heart (10) according to a CRT setting of the at least one future optimal CRT setting. The embodiments therefore enable efficient cardiac resynchronization therapy without any sensor readings after the end of the optimization time period and can therefore provide cardiac resynchronization therapy even if the hemodynamic sensor (240) becomes inoperable.

Abstract: In an implantable medical device and a method for monitoring ventricular synchronicity of a heart. In particular, impedance signals are measured and an occurrence of a notch is detected in the impedance signal coincident with a period including a change from rapid to slow filling of a ventricle. The notch is indicated by a first positive slope change in a negative slope in a predetermined time window during a diastolic phase of a cardiac cycle. A degree of synchronicity is determined based on the notch feature, wherein a decreasing notch feature indicates an increased degree of synchronicity in the filling phase of the ventricles.

Abstract: An implantable medical lead (1) comprises multiple electrodes (22, 24, 26, 28) arranged at a distal end (2), multiple electrode terminals (32, 34, 36, 38) at a proximal end (3) and a lead body (4) with an insulating tubing (40). A conductor coil (10) comprises a coiled tubular insulator (19) having multiple separate lumens (12, 14, 16, 18). Each lumen (12, 14, 16, 18) houses a respective conductor (11, 13, 15, 7), which is movable in the lumen (12, 14, 16, 18) relative the coiled tubular insulator (19). The conductor coil (10) is arranged in a bore (42) of the insulating tubing (40) and each conductor (11, 13, 15, 7) is electrically connected to one of the electrodes (22, 24, 26, 28) and one of the electrode terminals (32, 34, 36, 38).

Abstract: In a method and an implantable medical device for assessing a degree of pulmonary edema of a patient, at least two specific body patients of the patent are detected and at least one impedance sensing session is initiated to sense trans-thoracic impedance signals from the patient when the patient is in one of the at least two specific positions. Impedance values are obtained from the impedance signals, and a relation between respective impedance values at the at least two positions is determined. This relation is then used as a metric of pulmonary edema to assess the degree of pulmonary edema, and is provided as an output.

Abstract: The present invention relates to methods for manufacturing active fixation helices for the stimulation and/or sensing of organs. A first embodiment of a method in accordance with the present invention for making a helix comprises a first step of producing an elongated helix precursor body comprising one or more electrical conductors surrounded by an insulating material. This helix precursor body is then shaped into a helix, material removed in predetermined places in order to expose the areas of the conductors which will be used as electrodes in the final product. The body is coated with an electrically conducting biocompatible coating which is subsequently partly removed in continuous loops from around the electrodes in order to electrically insulate them from each other and to ensure that the electrically active areas of the electrodes are of the correct dimensions.

Abstract: In an implantable medical device and a method for stimulating a heart of a patient, at least one left atrial pressure (LAP) signal over a cardiac cycle is obtained. The A-wave is identified using the LAP signal and a maximum positive rate of change of the A-wave of the LAP signal is determined. The maximum positive rate of change of the A-wave corresponds to the rate which the pressure in the atrium raises as the atria contraction forces more blood into the ventricle during the very last stage of diastole. Further, AV and/or VV delay is adjusted in response to the maximum positive rate of change of the A-wave, wherein a reduction of the maximum positive rate of change of the A-wave indicates an AV and/or VV delay providing an enhanced hemodynamic performance.

Abstract: In a medical telemetry system for synchronizing an implantable medical device to a base station of the telemetry system, a communication channel is selected for communication between the implantable medical device and the base station, and the implantable medical device is synchronized to the base station by selecting a synchronizing word associated with the selected channel, wherein at least two different communication channels within the medical telemetry system are associated with different synchronization words. By this procedure, crosstalk is eliminated.

Abstract: An implantable medical device is stored in a container prior to implantation in body tissue. The IMD includes transmitter/receiver circuitry and at least one antenna. The storage container (packaging) includes an impedance altering substance positioned in proximity to the IMD when stored in the container, the substance having electrical material properties that alter the input impedance of the antenna to improve the reception and transmission properties of the antenna when the IMD is stored in the container. A container for storing an IMD having an antenna has a packaging tray for housing the IMD, the packaging tray having a support for supporting the IMD and the container including a substance positioned in proximity to the support that has electrical material properties that after the input impedance of the antenna of the IMD supported by the support, so as to improve the reception and transmission properties of the antenna.

Abstract: An implantable medical device has an event detector that detects a predetermined cardiac event during a heart cycle of a subject. A reference time is assigned to this detected cardiac event. An onset detector detects the onset of ventricular filling of the heart during the heart cycle. The relative time of the detected filling onset is determined based on the assigned time reference. An increased risk of heart failure of the subject is automatically determined based on the determined relative time for the filling onset. Generally, a reduction in the relative time, as determined at different points in time, indicates an increased heart failure risk or the presence of a heart failure condition.

Abstract: An implantable medical device is connectable to or comprises an activity sensor and determines a current activity level of a subject based on a sensor signal from the activity sensor. A time period during which the current activity level of the subject has exceeded a threshold level is also determined. A pulse generator controller controls a pulse generator to generate pacing pulses to be applied to the subject's heart at a pacing rate that is determined based on the current activity level and the length of the time period of activity at a level exceeding the threshold level.

Abstract: An assembly includes a medical implantable lead adapted to be attached with a distal end of the lead to an organ inside a human or animal body, the medical implantable lead being formed with an inner lumen extending along essentially the entire length of the lead. The assembly also includes a support core that has a desirable stiffness and a suitably cross sectional dimension such that it is insertable into the lumen (7) in order to increase the stiffness of the lead along its length during its working life when being implanted into a body. A method for implanting a medical implantable lead into a human or animal body makes use of such an assembly.

Abstract: A medical implantable lead adapted to be implanted into a human or animal body for monitoring and/or controlling of an organ inside the body has a fixation in a distal end, which is adapted to fix a distal end of the lead to the organ, an electrode member in the distal end adapted to be in contact with tissue of the organ and receive and/or transmit electrical signals from and/or to the organ, and at least one electrically conducting coil, which includes one or more electrically conducting helical wires and that is adapted to connect the electrode member in the distal end with a monitoring and/or controlling device in a proximal end of the lead. One or more of the individual wires of the coil has a wire core that is provided with a surrounding electrically insulating layer, which in turn is provided with a surrounding electrically conducting shield layer, and the coil is close lapped such that electrically conducting shield layers of adjacent loops of the coil are in electrical contact with each other.

Abstract: In a medical implantable lead of the type adapted to be implanted into a human or animal body for monitoring and/or controlling of an organ inside the body and a method for connecting such a lead to an organ in the human or animal body. The lead has a fixation arrangement at a distal end, and the fixation arrangement is adapted to penetrate into the tissue of the organ to fixate the lead to the organ. An electrode member is provided to receive and/or transmit electrical signals from or to the organ. The electrode member is resiliently pre-strained toward the distal end of the lead and is provided with an electrode surface such that the electrode surface will resiliently abut toward the outer surface of the organ when the fixation arrangement is fixed to the tissue.

Abstract: An implantable electrode lead for tissue stimulation adapted to be attached to an implantable tissue stimulator provided with a pulse generator, has at least two stimulation electrodes to apply stimulation pulses to said tissue and arranged close to the distal end of the electrode lead, and at least two electrical conductors to connect said electrodes to said pulse generator. The electrode lead further has a switching unit arranged close to the distal end of the electrode lead and adapted to switch the electrode lead between a local pacing mode and a normal pacing mode, the switching unit being controlled by a mode control signal. Further, a pacing module is arranged close to the distal end of the electrode lead and in relation to the switching unit and being connectable to said at least two stimulation electrodes, the pacing module includes a pulse generating unit to generate stimulating pulses to be applied to the tissue by the stimulation electrodes.

Abstract: An implantable medical device comprises a connector connectable to an implantable oxygen sensor configured to generate a sensor signal representative of oxygen concentration in coronary sinus blood in a subject's heart. An ischemia detector is connected to the connector and configured to detect an ischemic event in the heart if the sensor signal indicates a temporary decrease in oxygen concentration in the coronary sinus blood below a normal level followed by a temporary increase in oxygen concentration in the coronary sinus blood above the normal level.

Abstract: An analyte measuring system has an implantable medical device having a signal source arranged for generating a current signal and electrodes for applying the current signal to a surrounding tissue in a subject body. The device measures a resulting voltage signal with the electrodes and calculates an impedance signal therefrom. The system comprises a signal processor arranged for generating an estimate of a concentration of an analyte in the tissue based on a spectrum analysis of the determined impedance signal.

Abstract: The implantable medical device for measuring pressure is disclosed. The implantable medical device is connectable to a medical lead and comprises an outer sheath and a helically shaped needle arranged at the outer sheath. A pressure sensing body having a distal part is movably arranged in the outer sheath. The pressure sensing body is arranged such that the distal part is located within the outer sheath in an initial state of the pressure sensing body, wherein the pressure sensing body is arranged to be advanced from the initial state to protrude from the outer sheath and such that it is at least partially surrounded by the helically shaped needle; and a pressure sensor arranged at or adjacent to the distal part of the pressure sensing body for sensing pressure.

Abstract: A tissue stimulating device that provides a biological stimulation of tissue has a release surface adapted for arrangement adjacent to a tissue to be stimulated. An agent reservoir of the device includes an ionic agent capable of causing a stimulation if present at sufficient high extracellular concentration close to the tissue. An agent releaser is provided in the device for releasing a selected amount of the ionic agent from the agent reservoir to an outside of the release surface at a stimulation occasion for stimulating the tissue. The ionic agent will cause a temporary change in ion permeability of the tissue cell membranes and a depolarization of the tissue cells.